Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Epix Pharmaceuticals has announced that Michael Kauffman has resigned his position as CEO and director, to pursue other opportunities.
Subscribe to our email newsletter
Mr Kauffman joined Epix in August 2006 in connection with its acquisition of Predix Pharmaceuticals Holdings, where he had served as CEO since September 2002. Epix also named his replacement with the appointment of Elkan Gamzu, as interim CEO.
Mr Gamzu is currently a consultant to the biotechnology and pharmaceutical industries and has held a number of senior executive positions in many pharmaceutical companies like Millennium Pharmaceuticals and Hoffmann-La Roche.
Frederick Frank, chairman of the board of directors of Epix , said: “We thank Michael for his leadership and many contributions to Epix during his tenure as CEO.”